Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

The O-Antigen Epitope Governs Susceptibility to Colistin in Salmonella enterica.

Ricci V, Zhang D, Teale C, Piddock LJV.

mBio. 2020 Jan 28;11(1). pii: e02831-19. doi: 10.1128/mBio.02831-19.

2.

Over-expression of RamA, which regulates production of the MDR efflux pump AcrAB-TolC, increases mutation rate and influences drug-resistance phenotype.

Grimsey EM, Weston N, Ricci V, Stone JW, Piddock LJV.

Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02460-19. doi: 10.1128/AAC.02460-19. [Epub ahead of print]

PMID:
31988103
3.

In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae.

Foerster S, Drusano G, Golparian D, Neely M, Piddock LJV, Alirol E, Unemo M.

J Antimicrob Chemother. 2019 Dec 1;74(12):3521-3529. doi: 10.1093/jac/dkz376.

PMID:
31730160
4.

High-throughput sequencing data and antibiotic resistance mechanisms of soil microbial communities in non-irrigated and irrigated soils with raw sewage in African cities.

Bougnom BP, Thiele-Bruhn S, Ricci V, Zongo C, Piddock LJV.

Data Brief. 2019 Oct 15;27:104638. doi: 10.1016/j.dib.2019.104638. eCollection 2019 Dec.

5.

Opening Pandora's box: high level resistance to antibiotics of last resort in Gram negative bacteria from Nigeria.

Ogbolu DO, Piddock LJV, Webber MA.

J Glob Antimicrob Resist. 2019 Oct 22. pii: S2213-7165(19)30270-X. doi: 10.1016/j.jgar.2019.10.016. [Epub ahead of print]

6.

The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.

Piddock LJV.

J Antimicrob Chemother. 2019 Nov 1;74(11):3128-3134. doi: 10.1093/jac/dkz370.

PMID:
31626705
7.

Raw wastewater irrigation for urban agriculture in three African cities increases the abundance of transferable antibiotic resistance genes in soil, including those encoding extended spectrum β-lactamases (ESBLs).

Bougnom BP, Thiele-Bruhn S, Ricci V, Zongo C, Piddock LJV.

Sci Total Environ. 2020 Jan 1;698:134201. doi: 10.1016/j.scitotenv.2019.134201. Epub 2019 Sep 3.

PMID:
31505362
8.

Non-traditional Antibacterial Therapeutic Options and Challenges.

Theuretzbacher U, Piddock LJV.

Cell Host Microbe. 2019 Jul 10;26(1):61-72. doi: 10.1016/j.chom.2019.06.004. Review.

PMID:
31295426
9.

Do phenothiazines possess antimicrobial and efflux inhibitory properties?

Grimsey EM, Piddock LJV.

FEMS Microbiol Rev. 2019 Nov 1;43(6):577-590. doi: 10.1093/femsre/fuz017.

PMID:
31216574
10.

Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway.

Benedikz EK, Bailey D, Cook CNL, Gonçalves-Carneiro D, Buckner MMC, Blair JMA, Wells TJ, Fletcher NF, Goodall M, Flores-Langarica A, Kingsley RA, Madsen J, Teeling J, Johnston SL, MacLennan CA, Balfe P, Henderson IR, Piddock LJV, Cunningham AF, McKeating JA.

Sci Rep. 2019 May 27;9(1):7903. doi: 10.1038/s41598-019-44263-7.

11.

Antibiotic resistance genes are abundant and diverse in raw sewage used for urban agriculture in Africa and associated with urban population density.

Bougnom BP, McNally A, Etoa FX, Piddock LJ.

Environ Pollut. 2019 Aug;251:146-154. doi: 10.1016/j.envpol.2019.04.056. Epub 2019 Apr 30.

PMID:
31078086
12.
13.

Acquisition and Loss of CTX-M-Producing and Non-Producing Escherichia coli in the Fecal Microbiome of Travelers to South Asia.

Bevan ER, McNally A, Thomas CM, Piddock LJV, Hawkey PM.

mBio. 2018 Dec 11;9(6). pii: e02408-18. doi: 10.1128/mBio.02408-18.

14.

The Global Antibiotic Research and Development Partnership (GARDP): a not-for-profit antibiotic development organisation.

Piddock LJ; GARDP.

Lancet Infect Dis. 2018 Dec;18(12):1304-1305. doi: 10.1016/S1473-3099(18)30661-3. Epub 2018 Nov 9. No abstract available.

PMID:
30420229
15.

Wastewater used for urban agriculture in West Africa as a reservoir for antibacterial resistance dissemination.

Bougnom BP, Zongo C, McNally A, Ricci V, Etoa FX, Thiele-Bruhn S, Piddock LJV.

Environ Res. 2019 Jan;168:14-24. doi: 10.1016/j.envres.2018.09.022. Epub 2018 Sep 18.

PMID:
30253312
16.

Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing.

Buckner MMC, Ciusa ML, Piddock LJV.

FEMS Microbiol Rev. 2018 Nov 1;42(6):781-804. doi: 10.1093/femsre/fuy031. Review.

17.

Author Correction: Multidrug efflux pumps: structure, function and regulation.

Du D, Wang-Kan X, Neuberger A, van Veen HW, Pos KM, Piddock LJV, Luisi BF.

Nat Rev Microbiol. 2018 Sep;16(9):577. doi: 10.1038/s41579-018-0060-x.

PMID:
30022105
18.

Multidrug efflux pumps: structure, function and regulation.

Du D, Wang-Kan X, Neuberger A, van Veen HW, Pos KM, Piddock LJV, Luisi BF.

Nat Rev Microbiol. 2018 Sep;16(9):523-539. doi: 10.1038/s41579-018-0048-6. Review. Erratum in: Nat Rev Microbiol. 2018 Jul 18;:.

PMID:
30002505
19.

Revitalizing the drug pipeline: AntibioticDB, an open access database to aid antibacterial research and development.

Farrell LJ, Lo R, Wanford JJ, Jenkins A, Maxwell A, Piddock LJV.

J Antimicrob Chemother. 2018 Sep 1;73(9):2284-2297. doi: 10.1093/jac/dky208.

PMID:
29897476
20.

Clinically Relevant Plasmid-Host Interactions Indicate that Transcriptional and Not Genomic Modifications Ameliorate Fitness Costs of Klebsiella pneumoniae Carbapenemase-Carrying Plasmids.

Buckner MMC, Saw HTH, Osagie RN, McNally A, Ricci V, Wand ME, Woodford N, Ivens A, Webber MA, Piddock LJV.

mBio. 2018 Apr 24;9(2). pii: e02303-17. doi: 10.1128/mBio.02303-17.

21.

Discovery and development of new antibacterial drugs: learning from experience?

Jackson N, Czaplewski L, Piddock LJV.

J Antimicrob Chemother. 2018 Jun 1;73(6):1452-1459. doi: 10.1093/jac/dky019. Review.

PMID:
29438542
22.

The multiple antibiotic resistance operon of enteric bacteria controls DNA repair and outer membrane integrity.

Sharma P, Haycocks JRJ, Middlemiss AD, Kettles RA, Sellars LE, Ricci V, Piddock LJV, Grainger DC.

Nat Commun. 2017 Nov 13;8(1):1444. doi: 10.1038/s41467-017-01405-7.

23.

Addressing antimicrobial resistance in the UK and Europe.

Wells V, Piddock LJV.

Lancet Infect Dis. 2017 Dec;17(12):1230-1231. doi: 10.1016/S1473-3099(17)30633-3. Epub 2017 Nov 10. No abstract available.

PMID:
29133171
24.

Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae.

Weston N, Sharma P, Ricci V, Piddock LJV.

Res Microbiol. 2018 Sep - Oct;169(7-8):425-431. doi: 10.1016/j.resmic.2017.10.005. Epub 2017 Nov 8. Review.

PMID:
29128373
25.

Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan.

Webber MA, Buckner MMC, Redgrave LS, Ifill G, Mitchenall LA, Webb C, Iddles R, Maxwell A, Piddock LJV.

J Antimicrob Chemother. 2017 Oct 1;72(10):2755-2763. doi: 10.1093/jac/dkx201.

PMID:
29091182
26.

CsrA maximizes expression of the AcrAB multidrug resistance transporter.

Ricci V, Attah V, Overton T, Grainger DC, Piddock LJV.

Nucleic Acids Res. 2017 Dec 15;45(22):12798-12807. doi: 10.1093/nar/gkx929.

27.

Understanding drug resistance will improve the treatment of bacterial infections.

Piddock LJV.

Nat Rev Microbiol. 2017 Oct 12;15(11):639-640. doi: 10.1038/nrmicro.2017.121. No abstract available.

PMID:
29021594
28.

Lack of AcrB Efflux Function Confers Loss of Virulence on Salmonella enterica Serovar Typhimurium.

Wang-Kan X, Blair JMA, Chirullo B, Betts J, La Ragione RM, Ivens A, Ricci V, Opperman TJ, Piddock LJV.

mBio. 2017 Jul 18;8(4). pii: e00968-17. doi: 10.1128/mBio.00968-17.

29.

To the G20: incentivising antibacterial research and development.

Årdal C, Baraldi E, Ciabuschi F, Outterson K, Rex JH, Piddock LJV, Findlay D; DRIVE-AB Steering Committee.

Lancet Infect Dis. 2017 Aug;17(8):799-801. doi: 10.1016/S1473-3099(17)30404-8. Epub 2017 Jul 7. No abstract available.

PMID:
28689703
30.

Wastewater for Urban Agriculture: A Significant Factor in Dissemination of Antibiotic Resistance.

Bougnom BP, Piddock LJV.

Environ Sci Technol. 2017 Jun 6;51(11):5863-5864. doi: 10.1021/acs.est.7b01852. Epub 2017 May 10. No abstract available.

PMID:
28489349
31.

Beyond Antimicrobial Resistance: Evidence for a Distinct Role of the AcrD Efflux Pump in Salmonella Biology.

Buckner MM, Blair JM, La Ragione RM, Newcombe J, Dwyer DJ, Ivens A, Piddock LJ.

mBio. 2016 Nov 22;7(6). pii: e01916-16. doi: 10.1128/mBio.01916-16.

32.

Assess drug-resistance phenotypes, not just genotypes.

Piddock LJ.

Nat Microbiol. 2016 Jul 26;1(8):16120. doi: 10.1038/nmicrobiol.2016.120. No abstract available.

PMID:
27573119
33.

How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps.

Blair JM, Piddock LJ.

mBio. 2016 Jul 5;7(4). pii: e00840-16. doi: 10.1128/mBio.00840-16. Review.

34.

Erratum for Richmond et al., The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner.

Richmond GE, Evans LP, Anderson MJ, Wand ME, Bonney LC, Ivens A, Chua KL, Webber MA, Sutton JM, Peterson ML, Piddock LJ.

mBio. 2016 Jun 21;7(3). pii: e00852-16. doi: 10.1128/mBio.00852-16. No abstract available.

35.

Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance.

Piddock LJV.

Lancet Infect Dis. 2016 Jul;16(7):767-768. doi: 10.1016/S1473-3099(16)30127-X. Epub 2016 May 18. No abstract available.

PMID:
27208976
36.

The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner.

Richmond GE, Evans LP, Anderson MJ, Wand ME, Bonney LC, Ivens A, Chua KL, Webber MA, Sutton JM, Peterson ML, Piddock LJ.

mBio. 2016 Apr 19;7(2):e00430-16. doi: 10.1128/mBio.00430-16. Erratum in: MBio. 2016;7(3). pii: e00852-16. doi: 10.1128/mBio.00852-16.

37.

Ciprofloxacin and ceftriaxone alter cytokine responses, but not Toll-like receptors, to Salmonella infection in vitro.

Anuforom O, Wallace GR, Buckner MM, Piddock LJ.

J Antimicrob Chemother. 2016 Jul;71(7):1826-33. doi: 10.1093/jac/dkw092. Epub 2016 Apr 13.

PMID:
27076102
38.

Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.

Saw HT, Webber MA, Mushtaq S, Woodford N, Piddock LJ.

J Antimicrob Chemother. 2016 Jun;71(6):1510-9. doi: 10.1093/jac/dkw028. Epub 2016 Mar 5.

PMID:
26945714
39.

Understanding the mechanisms and drivers of antimicrobial resistance.

Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ.

Lancet. 2016 Jan 9;387(10014):176-87. doi: 10.1016/S0140-6736(15)00473-0. Epub 2015 Nov 18. Review.

40.

Nonmedical Uses of Antibiotics: Time to Restrict Their Use?

Meek RW, Vyas H, Piddock LJ.

PLoS Biol. 2015 Oct 7;13(10):e1002266. doi: 10.1371/journal.pbio.1002266. eCollection 2015 Oct.

41.

Teixobactin, the first of a new class of antibiotics discovered by iChip technology?

Piddock LJ.

J Antimicrob Chemother. 2015 Oct;70(10):2679-80. doi: 10.1093/jac/dkv175. Epub 2015 Jun 18. Review.

PMID:
26089440
42.

Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure.

Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock LJ.

J Antimicrob Chemother. 2015 Aug;70(8):2241-8. doi: 10.1093/jac/dkv109. Epub 2015 May 7.

43.

A novel gene amplification causes upregulation of the PatAB ABC transporter and fluoroquinolone resistance in Streptococcus pneumoniae.

Baylay AJ, Ivens A, Piddock LJ.

Antimicrob Agents Chemother. 2015;59(6):3098-108. doi: 10.1128/AAC.04858-14. Epub 2015 Mar 16.

44.

AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.

Blair JM, Bavro VN, Ricci V, Modi N, Cacciotto P, Kleinekathӧfer U, Ruggerone P, Vargiu AV, Baylay AJ, Smith HE, Brandon Y, Galloway D, Piddock LJ.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3511-6. doi: 10.1073/pnas.1419939112. Epub 2015 Mar 3.

45.

Molecular mechanisms of antibiotic resistance.

Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ.

Nat Rev Microbiol. 2015 Jan;13(1):42-51. doi: 10.1038/nrmicro3380. Epub 2014 Dec 1. Review.

PMID:
25435309
47.

Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.

Blair JM, Richmond GE, Piddock LJ.

Future Microbiol. 2014;9(10):1165-77. doi: 10.2217/fmb.14.66. Review.

PMID:
25405886
48.

Expression of homologous RND efflux pump genes is dependent upon AcrB expression: implications for efflux and virulence inhibitor design.

Blair JM, Smith HE, Ricci V, Lawler AJ, Thompson LJ, Piddock LJ.

J Antimicrob Chemother. 2015 Feb;70(2):424-31. doi: 10.1093/jac/dku380. Epub 2014 Oct 6.

49.

Understanding the basis of antibiotic resistance: a platform for drug discovery.

Piddock LJV.

Microbiology. 2014 Nov;160(Pt 11):2366-2373. doi: 10.1099/mic.0.082412-0. Epub 2014 Aug 13. Review.

PMID:
25122880
50.

UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study.

Bragginton EC, Piddock LJ.

Lancet Infect Dis. 2014 Sep;14(9):857-68. doi: 10.1016/S1473-3099(14)70825-4. Epub 2014 Jul 24.

PMID:
25065509

Supplemental Content

Loading ...
Support Center